Viral Vector Production and Molecular Cloning Platform (ViralForge IBSAL)
The IBSAL Viral Vector Production and Molecular Cloning Platform (ViralForge IBSAL) provides researchers with access to advanced genetic engineering and molecular virology technologies that facilitate the development of their basic, translational, and clinical research projects.
Introduction
The mission of the Viral Vector Production and Molecular Cloning Platform (ViralForge IBSAL) is to provide high-quality viral vectors (lentiviruses, retroviruses, and adeno-associated viruses / AAVs) produced and titrated under strict internal biosafety standards (containment level 2) and quality control measures (sterility, absence of mycoplasma, purity, transduction activity, etc.).
The service is staffed by highly specialized personnel and is equipped with the necessary facilities and infrastructure (P2 laboratories, ultracentrifuge equipment, molecular and cellular quality control systems, etc.) to ensure reproducible results and the highest level of biosafety.
Portfolio of services
- Production of lentiviruses (2nd and 3rd generation) and retroviruses
- Production of AAV vectors with common serotypes, retrograde delivery, etc.
- Comprehensive quality control of viral batches
- Generation of Stable Cell Lines
- Production of Viral Particles with a Special Charge
- Turnkey Projects
- Training and Consulting
- Expert consulting on genetic engineering design
- Custom Molecular Cloning
- Production and Purification of Viral-Grade Plasmids